H.R. 1796
Referred to CommitteeSickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Introduced 3/3/2025•119th Congress•House
Latest Action
Referred to the House Committee on Energy and Commerce.
3/3/2025 • House
Summary
Congress.gov has not published an official summary of this bill yet.
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (7)
Party Breakdown
5
Democrats
2
Republicans
0
Independents
Sponsor
R[
Cosponsors (6)
R[
R[
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
March 3, 2025
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House3/3/2025
Related Bills (4)
H.R. 7148
Consolidated Appropriations Act, 2026
RelatedView bill →
S. 891
Bipartisan Health Care Act
RelatedView bill →
S. 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
IdenticalView bill →
H.R. 1768
Lower Costs for Everyday Americans Act
RelatedView bill →